Ferumoxytol: A guide to its use in iron deficiency anaemia in adults with chronic kidney disease in the EU

被引:1
作者
Scott L.J. [1 ]
Lyseng-Williamson K.A. [1 ]
McCormack P.L. [1 ]
机构
[1] Adis 41, 0754 Auckland, Centorian Drive, Mairangi Bay, North Shore
关键词
Chronic Kidney Disease; Chronic Kidney Disease Patient; Iron Deficiency Anaemia; Serum Ferritin Level; Darbepoetin Alfa;
D O I
10.1007/s40267-013-0055-7
中图分类号
学科分类号
摘要
Ferumoxytol, a high-molecular-weight carbohydrate-iron complex, is indicated for the intravenous treatment of iron deficiency anaemia in adults with chronic kidney disease. In this population, a repletion course of intravenous ferumoxytol is significantly more effective than a short course of oral iron in increasing haemoglobin levels and improving most other iron indices, irrespective of whether patients are on haemodialysis or not on dialysis, and is generally well tolerated. © 2013 Springer International Publishing Switzerland.
引用
收藏
页码:223 / 227
页数:4
相关论文
共 12 条
  • [1] KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease, Am J Kidney Dis., 47, 5 SUPPL. 3, (2006)
  • [2] McCormack P.L., Ferumoxytol: In iron deficiency anaemia in adults with chronic kidney disease, Drugs, 72, 15, pp. 2013-2022, (2012)
  • [3] Macdougall I.C., Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: Oral or intravenous?, Curr Med Res Opin, 26, 2, pp. 473-482, (2010)
  • [4] Locatelli F., Aljama P., Barany P., Et al., Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure, Nephrol Dial Transplant, 19, SUPPL. 2, pp. 1-47, (2004)
  • [5] NICE Clinical Guideline 114: Anaemia Management in People with Chronic Kidney Disease, (2011)
  • [6] Feraheme (Ferumoxytol Injection): US Prescribing Information, (2011)
  • [7] Rienso (Ferumoxytol) 30 Mg/mL Solution for Injection: Summary of Product Characteristics, (2012)
  • [8] Spinowitz B.S., Kausz A.T., Baptista J., Et al., Ferumoxytol for treating iron deficiency anemia in CKD, J Am Soc Nephrol., 19, 8, pp. 1599-1605, (2008)
  • [9] Fishbane S., Bolton W.K., Winkelmayer W.C., Et al., Factors affecting response and tolerability to ferumoxytol in non-dialysis chronic kidney disease patients, Clin Nephrol, 78, 3, pp. 181-188, (2012)
  • [10] Provenzano R., Schiller B., Rao M., Et al., Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients, Clin J Am Soc Nephrol., 4, 2, pp. 386-393, (2009)